485
Views
129
CrossRef citations to date
0
Altmetric
Original Article

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

, , , , , , & show all
Pages 83-93 | Received 11 Jun 2004, Accepted 29 Sep 2004, Published online: 03 Jul 2009

References

  • Iosif C, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257–60
  • Iosif C. Effects of protracted administration of estriol on the lower urogenital tract in post-menopausal women. Arch Gynecol Obstet 1992; 51:115–20
  • Heimer G, Samsioe G. Effects of vaginally delivered estrogens. Acta Obstet Gynecol Scand Suppl 1996;163:1–2
  • Rigg L. Absorption of estrogens from vaginal creams. N Engl J Med 1978;278:195–7
  • Matsson LA, Cullberg G, Eriksson 0, Knutsson F. Vaginal administration of low-dose oestradiol — effects on the endometrium and vaginal cytology. Maturitas 1989,11:217–22
  • Sindberg Erikson P, Rasmussen H. Low-dose 17 beta estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo con-trolled study. Eur J Obstet Gynaecol Reprod Biol 1992;44:137–44
  • Nilsson K, Heimer G. Low-dose estradiol in the treatment of urogenital oestrogen deficiency — a pharmacokinetic and pharmacodynamic study. Maturitas 1992;15:121–7
  • Weisberg E, Fraser IS, Mishell DR Jr, Lacarra M. The acceptability of a combined oestrogen/ progestogen contraceptive vaginal ring. Contra-ception 1995;51:39–44
  • Nash HA, Alverez-Sanchez F, Mishell DR Jr, Fraser IS, Maruo T, Harmon TM. Estradiol-delivering vaginal rings for hormone replace-ment therapy. Am J Obstet Gynecol 1999;181:1400–6
  • Dezarnaulds G, Fraser IS. Vaginal ring delivery of hormone replacement therapy — a review. Expert Opin Pharmacother 2002;4:201–12
  • Speroff L. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. Obstet Gynecol 2003;102:823–34
  • Ayton RA, Darling GM, Murkies AL, et al. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with a conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351–8
  • Key T, Pike M. The dose-effect relationship between 'unopposed' oestrogens and endome-trial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Macmil-lan Press Ltd, 1988:205–12
  • Boman K, Strang P, Backstrom T, Gerdes U, Stendahl U. Influence of oestrogen on growth of endo-metrial carcinoma. Anticancer Res 1990;10:173–6
  • Barberi R. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992;166:740–5
  • Johansson C, Gunnarsson P. Pharmacokinetics of estradiol after application of an estradiol releasing vaginal ring. Research Report No: 20466 F, Kabi Pharmacia AB, Sweden, 1992
  • Hustin J, van den Eynde JP. Cytological evalua-tion of the effect of various estrogens given in menopause. Acta Cytol 1977;21:225–8
  • Coates H, King A. The Subject Assessment. A Handbook for Therapists. Edinburgh: Churchill Livingstone, 1982:91.
  • Skoldefors H, Carlstrom K, Furuhjelm M. Aging and urinary oestrogen excretion in the male. Acta Obstet Gynecol Scand 1975;54:89–90
  • Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epide-miol 1998;51:903–12
  • Casper F, Petri E and the Vaginal Ring Study Group. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multi-center study. Int Urogynecol J 1999;10:171–6
  • Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;7:73–80
  • Dessole S, Rubattu G, Abrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004; 11:49–56
  • Naessen T, Rodriguiz-Macias K. Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women. Am J Obstet Gynecol 2002;186:944–7
  • Bounds W, Szarewski A, Lowe D, Guillebaud J. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol 1993;48:123–5
  • Weisberg E, Fraser IS, Baker J, et al. A randomised comparison of the effects on vaginal and cervical epithelium of a placebo ring with non-use of a ring. Contraception 2000;62:83–9
  • Henriksson L, Stjernquist M, Boquist L, Cederg-ren I, Selinus I. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estrogen releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85–92
  • Eriksen PS, Rasmussen H. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo con-trolled study. Eur J Obstet Gynecol Reprod Biol 1992;44:137–44
  • Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7: 140–2
  • Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal wo-men. Am J Obstet Gynecol 1999;180:1072–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.